Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent.

However, the research found that exercising helped preserve bone loss. Experts said that the findings may apply to other ...

Recently, GLP-1 receptor agonist medications have been prescribed more commonly, in part due to their ability to produce ...

Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...

More importantly, it looks to establish whether DehdyraTECH processing results in higher brain absorption than non-DehydraTECH arms, with a focus on glucagon-like peptide 1 (“GLP-1”) drugs, ...

Some people lose more weight on drugs like Ozempic, Wegovy and Saxenda than others, and a new study reveals why that might be.

USA: The findings from a recent retrospective cohort study involving 3,389 patients with obesity revealed the effectiveness ...

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...

SEMAGLUTIDE. IS THERE BETTER KNOWN AS BRAND NAMES ... THANK YO Children who used the weight loss drug liraglutide in a ...

Recent studies suggest a potential link between semaglutide-based medications, such as Ozempic, and an increased risk of ...

Global data from WHO demonstrate a significant disproportionality for semaglutide and suicidal ideation compared with all medications.